How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
This Collection showcases original research on linear accelerator (LINAC) technologies, covering topics from the design and optimisation of LINAC components and beam diagnostics, to emerging ...
California cannot seek damages from 23andMe successor over 2023 data breach A U.S. bankruptcy judge on Friday said California cannot seek damages from the company formerly known as 23andMe arising ...
Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results